Matawan Pharmaceuticals - Retin-A's Unit Acquisition

Matawan Pharmaceuticals - Retin-A raised a round of funding on January 25, 2016. Investors include Perrigo.

Matawan Pharmaceuticals manufactures Retin-A, a cream for the treatment of acne. The company operates as a subsidiary of Rouses Point Pharmaceuticals.…

Articles about Matawan Pharmaceuticals - Retin-A's Unit Acquisition: